RUNX1T1 and myeloid sarcoma: RUNX1‐RUNX1T1 was the most common gene fusion in MS (16/42, 38.1%), and its frequency in MS is much higher than that in the Chinese AML study (38.1% vs. 10.7%) (Figure 1C).40